Curis (CRIS) Share-based Compensation (2010 - 2026)
Curis (CRIS) reported Share-based Compensation of $575000.0 for Q1 2026, down 50.6% on a YoY basis from $1.2 million in Q1 2025, and down 27.67% quarter-over-quarter from $795000.0 in Q4 2025.
Curis (CRIS) Share-based Compensation (2010 - 2026) Analysis & Trends
Curis has reported Share-based Compensation for 17 years, with the latest figure at $575000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 50.6% year-over-year to $575000.0; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (down 38.02% YoY), and the FY2025 full-year result was $4.0 million, down 32.21% from the prior year.
- Share-based Compensation for Q1 2026 stood at $575000.0, down from $795000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $2.0 million in Q2 2022, with the low at $575000.0 in Q1 2026.
- Historically, Share-based Compensation has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation jumped 56.32% — and 2026, when it tumbled 50.6%.
- Curis' Share-based Compensation stood at $1.7 million in 2022, then dropped by 11.24% to $1.5 million in 2023, then slipped by 17.31% to $1.3 million in 2024, then tumbled by 37.89% to $795000.0 in 2025, then slipped by 27.67% to $575000.0 in 2026.
- The last three Share-based Compensation figures came in at $575000.0 (Q1 2026), $795000.0 (Q4 2025), and $924000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 26.47 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 575,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 575,000.00 |
| Mar 31, 2026 | 575,000.00 |
| Dec 31, 2025 | 795,000.00 |
| Dec 31, 2025 | 795,000.00 |
| Sep 30, 2025 | 924,000.00 |
| Sep 30, 2025 | 924,000.00 |
| Jun 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Dec 31, 2023 | 1.55 Mn |